Evidence map›Paper›PMID 40825634›Full record

ArticleAnalytica chimica acta2025

Aminated cinnamic acid analogs as dual polarity matrices for high spatial resolution MALDI imaging mass spectrometry.

Martin Dufresne, Lukasz G Migas, Katerina V Djambazova, Madeline E Colley, Raf Van de Plas, Jeffrey M Spraggins

Abstract read
In one paragraph

Article in Analytica chimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. High-Specificity and Sensitivity Imaging of Neutral Lipids Using Salt-Enhanced MALDI TIMS.Journal of the American Society for Mass Spectrometry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin DufresneMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
Lukasz G MigasDelft Center for Systems and Control, Delft University of Technology, Delft, Netherlands.
Katerina V DjambazovaMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
Madeline E ColleyMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
Raf Van de PlasMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA; Delft Center for Systems and Control, Delft University of Technology, Delft, Netherlands; Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.
Jeffrey M SpragginsMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA; Department of Biochemistry, Vanderbilt University, Nashville, TN, USA; Department of Chemistry, Vanderbilt University, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN, USA. Electronic address: Jeff.spraggins@vanderbilt.edu.

Funding

Vanderbilt University Biomolecular Multimodal Imaging Center for 3-Dimensional Mapping of the Human KidneyU54DK134302 · NIDDK · VANDERBILT UNIVERSITY · PI SPRAGGINS, JEFFREY M · 2022 to 2025
$7.1M
VANDERBILT NEPHROLOGY TRAINING PROGRAMT32DK007569 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, RAYMOND C., IKIZLER, TALAT ALP · 1988 to 2024
$5.8M
Elucidating Molecular Drivers of Aging and Alzheimer's Disease via Multimodal Imaging Mass SpectrometryR01AG078803 · NIA · VANDERBILT UNIVERSITY · PI Rena A. S. Robinson, Matthew Schrag · 2022 to 2026
$3.5M
Multimodal Imaging Mass Spectrometry and Spatial Omics for the Human KidneyU01DK133766 · NIDDK · VANDERBILT UNIVERSITY · PI Jeffrey M Spraggins · 2022 to 2026
$3.4M
NIA NIH HHS R01 AG078803NIDDK NIH HHS T32 DK007569NIDDK NIH HHS U01 DK133766NIDDK NIH HHS U54 DK134302
6 · The paper itself

Abstract

backgroundWe have developed a new class of dual polarity molecules for matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) capable of acquiring 5 μm pixel sizes with high sensitivity toward polar lipids and metabolites. Aminated cinnamic acid analogs (ACAAs) are vacuum stable, have high extinction coefficients at 355 nm, are highly sensitive to polar lipids, have low toxicity, and are affordable. Current molecules used for high spatial resolution MALDI IMS of polar lipids have shown great success, but are plagued with issues such as low sensitivity at high spatial resolution, vacuum instability, and/or high toxicity.

resultsACAAs were evaluated as MALDI matrices, testing them for vacuum stability, absorption at 355 nm, crystal size, sensitivity, and molecular coverage. Among them, 4-aminocinnamic acid (ACA) and 4-(dimethylamino)cinnamic acid (DMACA) were found to perform better than conventional MALDI matrices for lipid IMS experiments. ACA generated fewer in-source fragments due to its high extinction coefficient at 355 nm. This leads to better discernment of thermally labile molecules such as gangliosides compared to typical 'soft' ionization matrices like DHA using murine brain tissue. On the other hand, DMACA showed better optical properties than ACA, giving it higher sensitivity from many lipid classes, such as phospholipids and sulfatides. DMACA outperformed DAN and DHA at their individually optimized laser power at small pixel sizes (≤10 μm). DMACA also allows for lower laser power to be used without compromising sensitivity, which reduced the laser spot size at the sample surface from ∼6 μm to ∼4.5 μm without hardware modifications. SIGNIFICANCE: Improved sensitivity and absorption efficiency at 355 nm allow for 5 μm pixel size MALDI IMS without oversampling while maintaining high S/N on commercial mass spectrometry platforms. Performing MALDI experiments at reduced laser energies minimizes tissue damage, enabling advanced multimodal MALDI IMS studies to be performed on single tissue sections. Comparisons and optimized MALDI IMS methods were performed on murine tissues and human kidney samples as part of the Human Biomolecular Atlas Program.

Indexed as

CinnamatesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnimalsMiceCinnamatescinnamic acid4-Aminocinnamic acid (ACA)4-Dimethylaminocinnamic acid (DMACA)Chemical matrixHigh spatial resolutionImaging mass spectrometryLipidsMatrix-assisted laser desorption/ionization (MALDI)timsTOF

Identifiers

PMID40825634
PMCPMC13072433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.